Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1

Status

Suspended 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 8Breast 3Other 2

Conditions

Breast Neoplasms 3Vaginitis 1Sexual Dysfunctions, Psychological 1Dyspareunia 1

Interventions

Trastuzumab 696Paclitaxel 679Cyclophosphamide 634Docetaxel 554Capecitabine 468Letrozole 407Carboplatin 393Fulvestrant 379Doxorubicin 330Tamoxifen 288pembrolizumab 272Anastrozole 252Epirubicin 249exemestane 238pertuzumab 229Bevacizumab 214Radiotherapy 213Gemcitabine 211Vinorelbine 188palbociclib 183Lapatinib 175130-nm albumin-bound paclitaxel 168Albumin-Bound Paclitaxel 156Exercise 147Magnetic Resonance Spectroscopy 145eribulin 144Taxes 134Fluorouracil 131Everolimus 118Cisplatin 118

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Testosterone Propionate × Breast × Clear all
NCT00080756 2024-08-28

Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease

City of Hope Medical Center

Phase 2 Active not recruiting
11 enrolled
Breast

Breast Neoplasms

NCT00612742 2021-10-29

BLOOM

BioSante Pharmaceuticals

Phase 3 Completed
3,656 enrolled
BreastOther

Breast Neoplasms, Sexual Dysfunctions, Psychological

NCT01122342 2010-05-13

Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer.

University of Vermont

Phase 1/2 Suspended
30 enrolled
Breast

Breast Neoplasms, Dyspareunia, Vaginitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡